Publications

5674 Results

SWOG S0221: A phase III trial comparing chemotherapy schedules in high-risk early breast cancer

Authors
GT Budd;W Barlow;HCF Moore;T Hobday;JA Stewart;C Isaacs;M Salim;J Cho;K Rinn;K Albain;H Chew;GV Burton;TD Moore;G Srkalovic;BA McGregor;LE Flaherty;RB Livingston;DL Lew;JR Gralow;GN Hortobagyi
Journal / Conference
Journal of Clinical Oncology 33(1):58-64
Year
2015
Research Committee(s)
Breast
PMID
PMID25422488
PMC
PMC4268253
Study Number(s)
S0221

Pharmacogenetic analysis of INT 0144 trial: association of polymorphisms with survival and toxicity in rectal cancer patients treated with 5-FU and radiation

Authors
P Bohanes;C Rankin;H Lenz;T Winder;C Ulrich;S Smalley;K Danenberg;K Makar;W Zhang;J Benedetti;C Blanke
Journal / Conference
Clinical Cancer Research Apr 1;21(7):1583-1590
Year
2015
Research Committee(s)
Gastrointestinal
PMID
PMID25589620
PMC
PMC4566931
Study Number(s)
SWOG-9304 (INT-0144)

A phase III study of radiation therapy (RT) and O6-benzylguanine, (O6BG) plus BCNU versus RT and BCNU alone and methylation status in newly diagnosed GBM and gliosarcoma: SWOG study S0001

Authors
D Blumenthal;C Rankin;K Stelzer;A Spence;A Sloan;D Moore;K Yost;S Schulman;E Rushing
Journal / Conference
International Journal of Clinical Oncology Aug;20(4):650-658
Year
2015
Research Committee(s)
Brain
PMID
PMID25407559
PMC
PMC4465052
Study Number(s)
S0001

Ibritumomab Consolidation After 3 Cycles of CHOP Plus Radiotherapy in High-Risk Limited-Stage Aggressive B-cell Lymphoma: SWOG S0313

Authors
D Persky;TP Miller;J Unger;BD Stea;OW Press;LS Constine;K Barton;JW Friedberg;M Leblanc;RI Fisher
Journal / Conference
Blood Jan 8;125(2):236-241
Year
2015
Research Committee(s)
Lymphoma
PMID
PMID25395425
PMC
PMC4287635
Study Number(s)
S0313

Phase II study of mTOR inhibitor everolimus (RAD001) in advanced malignant pleural mesothelioma (MPM): SWOG S0722

Authors
S-H Ou;J Moon;L Garland;PC Mack;J Testa;A Tsao;A Wozniak;D Gandara
Journal / Conference
Journal of Thoracic Oncology, Feb; 10(2):387-391
Year
2015
Research Committee(s)
Lung
PMID
PMID25611229
PMC
PMC4304604
Study Number(s)
S0722

Prognostic significance of NPM1 mutations in the absence of FLT3-Internal Tandem Duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report

Authors
F Ostronoff;M Othus;A Burnett;E Estey;FR Appelbaum;A Evans;J Godwin;A Gilkes;K Kopecky;M Lazenby;AF List;M Fang;V Oehler;S Petersdorf;E Pogosova-Agadjanyan;J Radich;C Willman;S Meshinchi;DL Stirewalt
Journal / Conference
Journal of Clinical Oncology, Apr 1;33(10):1157-1164
Year
2015
Research Committee(s)
Leukemia
PMID
PMID25713434
PMC
PMC437285
Study Number(s)
S0106, SWOG-9031, SWOG-9333, SWOG-9500

The diffusion of docetaxel in patients presenting with metastatic prostate cancer

Authors
J Unger;D Hershman;D Martin;R Etzioni;WE Barlow;M LeBlanc;SR Ramsey
Journal / Conference
Journal of the National Cancer Institute Dec 24;107(2)
Year
2015
Research Committee(s)
Cancer Care Delivery and Outcomes and Comparative Effectiveness
PMID
PMID25540245
PMC
PMC4326312

Cell signalling-based classifier predicts response to induction therapy in elderly patients with acute myeloid leukemia

Authors
A Cesano;C Willman;K Kopecky;U Geyko;S Putta;B Louie;M Westfall;N Purvis;D Spellmeyer;C Marimpietri;J Hackett;J Shi;M Walker;X Sun;E Paietta;M Tallman;L Cripe;S Atwater;F Appelbaum;J Radich
Journal / Conference
PLOS ONE 2015 Apr 17;10(4):e0118485. doi: 10.1371/journal.pone.0118485
Year
2015
Research Committee(s)
Leukemia
PMID
PMID25884949
PMC
PMCID4401549
Study Number(s)
S0112, S0301, SWOG-9031, SWOG-9333

Circulating tumor cell telomerase activity as a prognostic marker for overall survival in metastatic castration resistant prostate cancer: results from SWOG S0421

Authors
A Goldkorn;B Ely;C Tangen;Y-C Tai;T Xu;H Li;P Twardowski;P Van Veldhuizen;N Agarwal;M Carducci;JP Monk;M Garzotto;P Mack;P Lara;C Higano;M Hussain;N Vogelzang;IM Thompson;R Cote;D Quinn
Journal / Conference
International Journal of Cancer Apr 15;136(8):1856-1862
Year
2015
Research Committee(s)
Genitourinary
PMID
PMID25219358
PMC
PMC4323674
Study Number(s)
S0421

Effect of finasteride on serum androstenedione and risk of prostate cancer within the Prostate Cancer Prevention Trial: differential effect on high and low grade disease

Authors
A Hoque;S Yao;C Till;AR Kristal;P Goodman;AW Hsing;CM Tangen;EA Platz;FZ Stanczyk;JK Reichardt;A vanBokhoven;ML Neuhouser;R Santella;WD Figg;DK Price;HL Parnes;SM Lippman;C Ambrosone;IM Thompson
Journal / Conference
Urology Mar;85(3):616-620
Year
2015
Research Committee(s)
Cancer Control
PMID
PMID25733274
PMC
PMC4348556
Study Number(s)
SWOG-9217